Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...

The difference between type 1 and type 2 diabetes is that people with type 2 have a wider variety of treatment options.

Medical experts recognize type 5 diabetes as separate from other types, requiring specialized treatment focusing on ...

Millions of microorganisms in the gut, known as the gut microbiome, play a crucial role in digestion and immunity. Research ...

The company has announced positive data from the ACHIEVE-2 and ACHIEVE-5 trials, with both meeting all their primary and key ...

People who have type 2 diabetes have an increased amount of sugar in their blood, also called blood glucose. Increased blood sugar happens when your body’s insulin doesn’t work as well as it should.

The American College of Lifestyle Medicine (ACLM) calls the new code “a major milestone for lifestyle medicine.” They note ...

Sodium-glucose cotransporter-2 (SGLT-2) inhibitors used to treat type 2 diabetes are associated with an 11% lower risk of ...

Eli Lilly’s oral GLP-1 therapy, orforglipron, met all primary and key secondary endpoints in the Phase III ACHIEVE-2 and ACHIEVE-5 studies, showing significant A1C reduction, weight loss, and ...

A hidden genetic variant found in Black and Asian men could cause delays in them being diagnosed with type 2 diabetes, new ...

Jardiance (empagliflozin) is a medicine for type 2 diabetes approved by the FDA in 2014. It is approved to help lower blood sugar levels in adults and children with type 2 diabetes and to lower the ...

New ICD-10 diagnosis code is for patients with history of type 2 diabetes who bring blood sugar levels to a non-diabetic range below 6.5% for at least 3 months.